Your session is about to expire
← Back to Search
Behavioural Intervention
Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study
N/A
Waitlist Available
Led By William A Ahroon, Ph.D.
Research Sponsored by United States Army Aeromedical Research Laboratory
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and two, four, and six months after enrollment
Summary
This trial tests a special sound therapy device designed to help soldiers and veterans with severe tinnitus. The device plays customized sounds, including music, to retrain the brain and reduce the perception of ringing in the ears. The goal is to improve their quality of life and ability to return to duty.
Eligible Conditions
- Tinnitus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and six months after enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and six months after enrollment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Tinnitus Reaction Questionnaire (TRQ)
Secondary study objectives
Hospital Anxiety and Depression Scale (HADS)
Loudness Discomfort Levels (LDL) (an audiometric test)
Minimum Masking Level (MML) (an audiometric test)
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Oasis™ deviceExperimental Treatment1 Intervention
Treatment using the Neuromonics Tinnitus Treatment Program and the Neuromonics Oasis™ treatment device.
Group II: Placebo devicePlacebo Group1 Intervention
Treatment using the Neuromonics Tinnitus Treatment Program and an identical-appearing placebo device.
Find a Location
Who is running the clinical trial?
United States Army Aeromedical Research LaboratoryLead Sponsor
4 Previous Clinical Trials
146 Total Patients Enrolled
Congressionally Directed Medical Research ProgramsFED
56 Previous Clinical Trials
10,180 Total Patients Enrolled
William A Ahroon, Ph.D.Principal InvestigatorU.S. Army Aeromedical Research Laboratory